Feng‐Hou Gao
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 7
- PI3K/AKT/mTOR signaling in cancer 4
- Cell death mechanisms and regulation 4
- Oncology top 10%
-
- interferon and immune responses 4
- Immunotherapy and Immune Responses 4
- Toxicology top 10%
-
- Neuroblastoma Research and Treatments 4
In The Last Decade
Feng‐Hou Gao
49 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 253
- Molecular Biology 886
- Oncology 346
- Immunology 191
- Toxicology 30
Countries citing papers authored by Feng‐Hou Gao
This map shows the geographic impact of Feng‐Hou Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Hou Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Hou Gao more than expected).
Fields of papers citing papers by Feng‐Hou Gao
This network shows the impact of papers produced by Feng‐Hou Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Hou Gao. The network helps show where Feng‐Hou Gao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng‐Hou Gao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 77 | |
| 6 | 2019 | 14 | |
| 7 | 2019 | 15 | |
| 8 | 2017 | 24 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 13 | |
| 11 | 2016 | 51 | |
| 12 | 2016 | 36 | |
| 13 | 2016 | 66 | |
| 14 | 2015 | 27 | |
| 15 | 2014 | 33 | |
| 16 | 2014 | 47 | |
| 17 | 2013 | 71 | |
| 18 | 2011 | 138 | |
| 19 | 2009 | 1 | |
| 20 | 2009 | 22 |
About Feng‐Hou Gao
Feng‐Hou Gao is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), interferon and immune responses (4 papers), MicroRNA in disease regulation (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cell death mechanisms and regulation (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer-related molecular mechanisms research (4 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Cancer Research (253 citations), Molecular Biology (886 citations) and Oncology (346 citations). Feng‐Hou Gao has collaborated with scholars based in China and Thailand. Frequent co-authors include Bin Jiang, Shanshan Yin, Yingli Wu, Mang‐Hua Xu, Jing Lu, Meng Zhao, Chen Chen, Bowen Jiang, Guo Zhu-ying and Haihua Yuan. Their work appears in journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.